Replies to post #100016 on Avid Bioservices Inc (CDMO)

[asmarterwookie]

Re: Pancreatic and 1st line NSCLC MOS...
We are still waiting for both control group and treatment arms.
We (unfortunately) hope for control group MOS first of course.
I say unfortunately because it hurts my heart thinking that people have to pass to reach MOS. : (.

wook

[EYEBUYSTOX]

Or at least not until Major discrepancies are found again, IMO. And that's the whole problem. If the company cannot recover the data from a gold standard FDA approved double blinded, placebo controlled multi-center trial HOW IN THE WORLD CAN ANYONE TRUST ANYTHING THE COMPANY EVER SAYS AS IT RELATES TO ANY FUTURE TRIAL EVER?!?!?! I'm not exaggerating. I'm curious how.

If the 2nd line NSCLC issue never gets resolved, this company is going nowhere. No data will be received well by the investment community, IMO. Even amazing pancreatic survival data will be mocked by everyone. Even if the lead investigator comes out and says it's a cure, the public will laugh. Until a partner steps up with a monetary commitment there are no trial results aside from FDA Audited 2nd line NSCLC results that will help the PPS. Anything the company says going forward is just fluff until then. It's sad...it really is. So many careers and so much hard work all screwed by some data mix up. So sad. All, IMO.

[nuke661]

Thanks for that info Dia.